Enteral glutamine infusion modulates ubiquitination of heat shock proteins, Grp-75 and Apg-2, in the human duodenal mucosa

[1]  C. Bole-Feysot,et al.  Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. , 2014, Clinical nutrition.

[2]  P. Déchelotte,et al.  Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation , 2013, Proteomics.

[3]  P. Déchelotte,et al.  Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. , 2013, Clinical nutrition.

[4]  P. Déchelotte,et al.  Regulation of intestinal protein metabolism by amino acids , 2012, Amino Acids.

[5]  Jie-shou Li,et al.  The Impact of Perioperative Glutamine-supplemented Parenteral Nutrition on Outcomes of Patients Undergoing Abdominal Surgery: A Meta-analysis of Randomized Clinical Trials , 2013, The American surgeon.

[6]  Xiaoyun Sun,et al.  Inflammatory response of microglial BV‐2 cells includes a glycolytic shift and is modulated by mitochondrial glucose‐regulated protein 75/mortalin , 2013, FEBS letters.

[7]  S. Lecleire,et al.  Enteral delivery of proteins stimulates protein synthesis in human duodenal mucosa in the fed state through a mammalian target of rapamycin-independent pathway. , 2013, The American journal of clinical nutrition.

[8]  C. Bole-Feysot,et al.  Glutamine induces nuclear degradation of the NF-κB p65 subunit in Caco-2/TC7 cells. , 2012, Biochimie.

[9]  M. Fukuzawa,et al.  Glutamine prevents intestinal mucosal injury induced by cyclophosphamide in rats , 2012, Pediatric Surgery International.

[10]  Kathryn E. Crosier,et al.  Zebrafish heat shock protein a4 genes in the intestinal epithelium are up‐regulated during inflammation , 2011, Genesis.

[11]  S. Lecleire,et al.  Effects of an enteral glucose supply on protein synthesis, proteolytic pathways, and proteome in human duodenal mucosa. , 2011, The American journal of clinical nutrition.

[12]  Arndt Hartmann,et al.  Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma , 2011, Molecular Cancer Research.

[13]  P. Wischmeyer,et al.  Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[14]  M. J. Clague,et al.  Ubiquitin: Same Molecule, Different Degradation Pathways , 2010, Cell.

[15]  S. Lecleire,et al.  Increased Proteasome-Mediated Degradation of Occludin in Irritable Bowel Syndrome , 2010, The American Journal of Gastroenterology.

[16]  P. Déchelotte,et al.  Potential for amino acids supplementation during inflammatory bowel diseases , 2010, Inflammatory bowel diseases.

[17]  J. Marchini,et al.  Glutamine supplementation does not improve protein synthesis rate by the jejunal mucosa of the malnourished rat. , 2009, Nutrition research.

[18]  J. Schulzke,et al.  Barrier Effects of Nutritional Factors , 2009, Annals of the New York Academy of Sciences.

[19]  S. Lecleire,et al.  Combined enteral infusion of glutamine, carbohydrates, and antioxidants modulates gut protein metabolism in humans. , 2008, The American journal of clinical nutrition.

[20]  J. Pérez‐Sánchez,et al.  Chronic exposure to the parasite Enteromyxum leei (Myxozoa: Myxosporea) modulates the immune response and the expression of growth, redox and immune relevant genes in gilthead sea bream, Sparus aurata L. , 2008, Fish & shellfish immunology.

[21]  M. Balda,et al.  Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2 , 2007, BMC Cell Biology.

[22]  J. Lemeland,et al.  Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock. , 2007, World Journal of Gastroenterology.

[23]  Fei Li,et al.  Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. , 2006, World journal of gastroenterology.

[24]  C. Loddenkemper,et al.  Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis , 2006 .

[25]  W. Dröge,et al.  Low Intestinal Glutamine Level and Low Glutaminase Activity in Crohn’s Disease: A Rational for Glutamine Supplementation? , 2006, Digestive Diseases and Sciences.

[26]  P. Ducrotte,et al.  Regulation of proteolysis by cytokines in the human intestinal epithelial cell line HCT-8: role of IFNgamma. , 2006, Biochimie.

[27]  P. Ducrotte,et al.  Glutamine Pretreatment Reduces IL-8 Production in Human Intestinal Epithelial Cells by Limiting IκBα Ubiquitination , 2006 .

[28]  P. Déchelotte,et al.  L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study* , 2006, Critical care medicine.

[29]  M. Balda,et al.  The heat-shock protein Apg-2 binds to the tight junction protein ZO-1 and regulates transcriptional activity of ZONAB. , 2005, Molecular biology of the cell.

[30]  Yan Zhang,et al.  [Effect of glutamine on the expression of grp75 in PC12 cells]. , 2005, Shi yan sheng wu xue bao.

[31]  J. Galloway,et al.  Parenteral glutamine increases serum heat shock protein 70 in critically ill patients , 2005, Intensive Care Medicine.

[32]  D. A. De-Souza,et al.  Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine* , 2005, Critical care medicine.

[33]  V. Baracos,et al.  Modulation of intestinal protein synthesis and protease mRNA by luminal and systemic nutrients. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[34]  P. Ducrotte,et al.  Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[35]  D. Darmaun,et al.  Does enteral glutamine modulate whole-body leucine kinetics in hypercatabolic dogs in a fed state? , 2002, Metabolism: clinical and experimental.

[36]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[37]  Karl Matter,et al.  The tight junction protein ZO‐1 and an interacting transcription factor regulate ErbB‐2 expression , 2000, The EMBO journal.

[38]  P. Calder,et al.  Glutamine and the immune system , 1999, Amino Acids.

[39]  L. Thijs,et al.  Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma , 1998, The Lancet.

[40]  D. Brenner,et al.  L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. , 1997, The American journal of physiology.

[41]  Y. Kaneko,et al.  Cloning of apg-2 encoding a novel member of heat shock protein 110 family. , 1997, Gene.

[42]  M. Rennie,et al.  Increased rates of duodenal mucosal protein synthesis in vivo in patients with untreated coelia disease. , 1996, Gut.

[43]  R. Morimoto,et al.  Cloning and Subcellular Localization of Human Mitochondrial hsp70 (*) , 1995, The Journal of Biological Chemistry.

[44]  S. Kaul,et al.  Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. , 1993, Experimental cell research.

[45]  M. Arnaout,et al.  Molecular cloning of a novel human hsp70 from a B cell line and its assignment to chromosome 5. , 1993, Journal of immunology.

[46]  S. Kaul,et al.  Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. , 1993, The Journal of biological chemistry.

[47]  W. Welch,et al.  The two mammalian mitochondrial stress proteins, grp 75 and hsp 58, transiently interact with newly synthesized mitochondrial proteins. , 1991, Cell regulation.

[48]  P. O’Farrell.  High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[49]  T. Carmona,et al.  l-Alanyl-l-glutamine Dipeptide-Supplemented Total Parenteral Nutrition , 2014 .

[50]  P. Déchelotte,et al.  Effects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathways , 2010, Amino Acids.

[51]  J. Daly.  Combined enteral infusion of glutamine, carbohydrates, and antioxidants modulates gut protein metabolism in humans , 2009 .

[52]  C. Bole-Feysot,et al.  Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. , 2009, American journal of physiology. Endocrinology and metabolism.

[53]  J. Daly.  L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study , 2008 .

[54]  C. Loddenkemper,et al.  Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. , 2006, The Journal of clinical investigation.

[55]  P. Ducrotte,et al.  Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaBalpha ubiquitination. , 2006, The Journal of nutrition.

[56]  W. Souba,et al.  Glutamine , 2000, World Journal of Surgery.

[57]  J. Monaco,et al.  The genetics of proteasomes and antigen processing. , 1995, Annual review of genetics.